Biote Corp (BTMD)
6.14
+0.08
(+1.32%)
USD |
NASDAQ |
Nov 21, 16:00
6.13
-0.01
(-0.16%)
After-Hours: 20:00
Biote Gross Profit Margin (Quarterly): 70.47% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 70.47% |
| June 30, 2024 | 68.91% |
| March 31, 2024 | 71.44% |
| December 31, 2023 | 69.36% |
| September 30, 2023 | 68.90% |
| June 30, 2023 | 67.87% |
| March 31, 2023 | 69.05% |
| Date | Value |
|---|---|
| December 31, 2022 | 65.33% |
| September 30, 2022 | 68.22% |
| June 30, 2022 | 67.27% |
| March 31, 2022 | 66.95% |
| December 31, 2021 | 63.97% |
| September 30, 2021 | 65.45% |
| June 30, 2021 | 66.50% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
63.97%
Minimum
Dec 2021
71.44%
Maximum
Mar 2024
67.83%
Average
68.04%
Median
Gross Profit Margin (Quarterly) Benchmarks
| American Shared Hospital Services | 19.57% |
| Omnicell Inc | 43.29% |
| Astrana Health Inc | 15.35% |
| Cryo-Cell International Inc | 73.65% |
| P3 Health Partners Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | 7.62% |
| Return on Invested Capital | 28.47% |
| Profit Margin (Quarterly) | 20.83% |
| Operating Margin (Quarterly) | 23.71% |
| Return on Net Operating Assets | 19.86% |